A detailed history of Cohen & Steers, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cohen & Steers, Inc. holds 6,000 shares of BMY stock, worth $280,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$280,860
Previous $278,000 2.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$44.12 - $59.6 $264,720 - $357,600
6,000 New
6,000 $278,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $14 Million - $17.5 Million
-277,521 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $1.93 Million - $2.22 Million
-32,176 Reduced 10.39%
277,521 $17.6 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $1.22 Million - $1.33 Million
20,323 Added 7.02%
309,697 $19 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $16 Million - $18.4 Million
289,374
289,374 $18.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cohen & Steers, Inc. Portfolio

Follow Cohen & Steers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen & Steers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cohen & Steers, Inc. with notifications on news.